![Comparing LAMA with LABA and LTRA as add-on therapies in primary care asthma management | npj Primary Care Respiratory Medicine Comparing LAMA with LABA and LTRA as add-on therapies in primary care asthma management | npj Primary Care Respiratory Medicine](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41533-020-00205-9/MediaObjects/41533_2020_205_Fig1_HTML.png)
Comparing LAMA with LABA and LTRA as add-on therapies in primary care asthma management | npj Primary Care Respiratory Medicine
![Inhalers! This is a follow-up from one of last weeks posts about the triple inhaler. We have 5 total inhalers that are … | Inhaler, Nebulizers, Combination therapy Inhalers! This is a follow-up from one of last weeks posts about the triple inhaler. We have 5 total inhalers that are … | Inhaler, Nebulizers, Combination therapy](https://i.pinimg.com/originals/ea/ed/5f/eaed5fda66fdba0cfbfbab28d8c0ee08.jpg)
Inhalers! This is a follow-up from one of last weeks posts about the triple inhaler. We have 5 total inhalers that are … | Inhaler, Nebulizers, Combination therapy
![Dr Nick Hopkinson on X: "New @NICEcomms 2018 COPD guideline update. Initial inhaler pathway - offer LAMA/LABA to most, consider LABA/ICS for some https://t.co/20Qy0Zc5DE @BTSrespiratory @lunguk #BTSWinter2018 4/6 https://t.co/uepZ7YPZsV" / X Dr Nick Hopkinson on X: "New @NICEcomms 2018 COPD guideline update. Initial inhaler pathway - offer LAMA/LABA to most, consider LABA/ICS for some https://t.co/20Qy0Zc5DE @BTSrespiratory @lunguk #BTSWinter2018 4/6 https://t.co/uepZ7YPZsV" / X](https://pbs.twimg.com/media/DtzVlWsWwAArrfB.jpg)
Dr Nick Hopkinson on X: "New @NICEcomms 2018 COPD guideline update. Initial inhaler pathway - offer LAMA/LABA to most, consider LABA/ICS for some https://t.co/20Qy0Zc5DE @BTSrespiratory @lunguk #BTSWinter2018 4/6 https://t.co/uepZ7YPZsV" / X
![Toby Capstick on X: "#Trelegy Ellipta: The second ICS/LAMA/LABA inhaler in the UK, licensed for #COPD. https://t.co/NSYtv7bTYS (An alternative ICS/LABA /LAMA inhaler is available: #Trimbow MDI) https://t.co/vQBgh9lvM2" / X Toby Capstick on X: "#Trelegy Ellipta: The second ICS/LAMA/LABA inhaler in the UK, licensed for #COPD. https://t.co/NSYtv7bTYS (An alternative ICS/LABA /LAMA inhaler is available: #Trimbow MDI) https://t.co/vQBgh9lvM2" / X](https://pbs.twimg.com/media/DPVNbspWkAErhbn.jpg)
Toby Capstick on X: "#Trelegy Ellipta: The second ICS/LAMA/LABA inhaler in the UK, licensed for #COPD. https://t.co/NSYtv7bTYS (An alternative ICS/LABA /LAMA inhaler is available: #Trimbow MDI) https://t.co/vQBgh9lvM2" / X
![Principal differences between inhaler devices used to deliver LAMA/LABA... | Download Scientific Diagram Principal differences between inhaler devices used to deliver LAMA/LABA... | Download Scientific Diagram](https://www.researchgate.net/publication/332642841/figure/tbl2/AS:751585386848265@1556203328958/Principal-differences-between-inhaler-devices-used-to-deliver-LAMA-LABA-FDC.png)
Principal differences between inhaler devices used to deliver LAMA/LABA... | Download Scientific Diagram
![實證醫學LAMA/LABA固定劑量組合吸入劑逐漸成為COPD治療主軸(LABA and LAMA in a combined inhaler versus placebo for COPD) - NEJS 實證醫學LAMA/LABA固定劑量組合吸入劑逐漸成為COPD治療主軸(LABA and LAMA in a combined inhaler versus placebo for COPD) - NEJS](https://1.bp.blogspot.com/-CRT07wUK_d4/XQQvFhKDnXI/AAAAAAAB2Og/-r-XFnw0TJUa1dFJuKaFFeYI_AG5qDacQCLcBGAs/s1600/NEJS%2B20141120.png)